Active Ingredient History
Nivolumab, sold under the brand name Opdivo, is a medication used to treat a number of types of cancer. This includes melanoma, lung cancer, malignant pleural mesothelioma, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colon cancer, esophageal squamous cell carcinoma, liver cancer, gastric cancer, and esophageal or gastroesophageal junction (GEJ) cancer. It is used by slow injection into a vein. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Ablation Techniques (Early Phase 1)
Adenocarcinoma (Phase 2)
Adenocarcinoma, Clear Cell (Phase 2)
Adenocarcinoma, Mucinous (Phase 2)
Adenocarcinoma of Lung (Phase 3)
Adenocarcinoma, Papillary (Phase 2)
Adrenal Gland Neoplasms (Phase 2)
Adrenocortical Carcinoma (Phase 2)
alpha-Fetoproteins (Phase 2)
Anemia (Phase 1)
Anemia, Refractory (Phase 1)
Antibodies, Neoplasm (Phase 1/Phase 2)
Anus Neoplasms (Phase 3)
Appendicitis (Phase 2)
Arthritis, Rheumatoid (Phase 1)
Astrocytoma (Phase 1)
Autoimmune Diseases (Phase 1)
Basal Cell Nevus Syndrome (Phase 2)
Bile Duct Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Biomarkers (Phase 1/Phase 2)
Bone Marrow Cells (Phase 2)
Brain Diseases (Phase 1)
Brain Neoplasms (Phase 3)
Breast Neoplasms (Phase 3)
Bronchopulmonary Dysplasia (Phase 2)
Burkitt Lymphoma (Phase 2)
Carcinoid Tumor (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Acinar Cell (Phase 2)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Adenosquamous (Phase 1)
Carcinoma, Basal Cell (Phase 2)
Carcinoma, Endometrioid (Phase 2)
Carcinoma, Giant Cell (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Merkel Cell (Phase 3)
Carcinoma, Mucoepidermoid (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 4)
Carcinoma, Signet Ring Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2/Phase 3)
Carcinoma, Transitional Cell (Phase 3)
Carcinosarcoma (Phase 2)
Castration (Phase 2)
Chemotherapy, Adjuvant (Phase 3)
Cholangiocarcinoma (Phase 3)
Chondrosarcoma (Phase 2)
Chordoma (Phase 2)
Choriocarcinoma (Phase 2)
Choroid Plexus Neoplasms (Phase 2)
Chromatin (Phase 2)
Chromosome Aberrations (Phase 2)
Circulating Tumor DNA (Phase 2)
Colitis, Ulcerative (Phase 1)
Colonic Neoplasms (Phase 3)
Colonic Polyps (Phase 2)
Colorectal Neoplasms (Phase 3)
Conjunctival Neoplasms (Phase 1)
COVID-19 (Phase 2)
Crohn Disease (Phase 1)
Cystadenocarcinoma, Mucinous (Phase 2)
Cystadenocarcinoma, Serous (Phase 2)
Dermatomyositis (Phase 1)
Desmoplastic Small Round Cell Tumor (Phase 2)
DNA Mismatch Repair (Phase 2)
Docetaxel (Phase 2)
Down Syndrome (Phase 2)
Drug Misuse (Phase 1/Phase 2)
Drugs, Investigational (Phase 1/Phase 2)
Endometrial Neoplasms (Phase 2)
Ependymoma (Phase 2)
Epigenetic Repression (Phase 2)
Epstein-Barr Virus Infections (Phase 2)
Esophageal Neoplasms (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 2)
Esophagogastric Junction (Phase 2)
Eye Diseases, Hereditary (Phase 1)
Fallopian Tube Neoplasms (Phase 3)
Fallopian Tubes (Phase 1)
Fibrosarcoma (Phase 1)
Gallbladder Neoplasms (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Gastrointestinal Stromal Tumors (Phase 2)
GATA2 Deficiency (Phase 1)
General Surgery (Phase 3)
Genes, erbB-2 (Phase 1)
Genital Neoplasms, Female (Phase 1/Phase 2)
Genital Neoplasms, Male (Phase 2)
Germ Cells (Phase 2)
Gestational Trophoblastic Disease (Phase 2)
Giant Cell Arteritis (Phase 1)
Glioblastoma (Phase 3)
Glioma (Phase 2)
Gliosarcoma (Phase 2/Phase 3)
Hamartoma (Phase 2)
Head and Neck Neoplasms (Phase 3)
Hemangiosarcoma (Phase 2)
Hematologic Neoplasms (Phase 1/Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 1)
Hepatitis B (Phase 1/Phase 2)
Hepatitis B, Chronic (Phase 2)
Hepatitis C (Phase 1)
Hepatitis C, Chronic (Phase 1)
Hepatomegaly (Phase 2)
Histiocytoma, Malignant Fibrous (Phase 1)
HIV Infections (Phase 2)
Hodgkin Disease (Phase 4)
HTLV-I Infections (Phase 2)
Hypopharyngeal Neoplasms (Phase 2)
Immune Checkpoint Inhibitors (Phase 1/Phase 2)
Immunity (Early Phase 1)
Immunosuppression Therapy (Early Phase 1)
Immunotherapy (Phase 1/Phase 2)
Inflammatory Bowel Diseases (Phase 1)
Intestinal Neoplasms (Phase 2)
Keratoacanthoma (Phase 2)
Kidney Diseases (Phase 2)
Kidney Neoplasms (Phase 4)
Laryngeal Neoplasms (Phase 2)
Larynx (Phase 2)
Leiomyosarcoma (Phase 2)
Leukemia (Phase 2)
Leukemia, B-Cell (Phase 1/Phase 2)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2/Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 1)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukoplakia, Oral (Phase 2)
Lip (Phase 2)
Lip Diseases (Early Phase 1)
Liposarcoma (Phase 2)
Liver Diseases (Phase 1)
Liver Neoplasms (Phase 4)
Lung Neoplasms (Phase 4)
Lupus Erythematosus, Systemic (Phase 1)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2/Phase 3)
Lymphoma, Primary Effusion (Phase 2)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 2)
Lymphoproliferative Disorders (Phase 2)
Medulloblastoma (Phase 2)
Melanoma ()
Meningeal Carcinomatosis (Phase 2)
Meningeal Neoplasms (Phase 1)
Meninges (Phase 1)
Meningioma (Phase 2)
Mesothelioma (Phase 3)
Mesothelioma, Malignant (Phase 2)
Methylation (Phase 1/Phase 2)
Microsatellite Instability (Phase 2)
Mouth Neoplasms (Phase 2)
Multiple Myeloma (Phase 3)
Multiple Pulmonary Nodules (Phase 2)
Multiple Sclerosis (Phase 1)
Mutation (Phase 2)
Mycosis Fungoides (Phase 2)
Myelodysplastic Syndromes (Phase 2/Phase 3)
Myeloid Cells (Phase 1)
Myeloproliferative Disorders (Phase 1)
Nasopharyngeal Carcinoma (Phase 3)
Nasopharyngeal Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms ()
Neoplasms, Adnexal and Skin Appendage (Phase 2)
Neoplasms by Site (Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Neoplasms, Multiple Primary (Phase 3)
Neoplasms, Squamous Cell (Phase 1/Phase 2)
Nerve Sheath Neoplasms (Phase 1)
Neuroblastoma (Phase 1/Phase 2)
Neuroendocrine Tumors (Phase 2)
Neurofibrosarcoma (Phase 2)
Nivolumab (Phase 2)
Oligodendroglioma (Phase 2)
Oncogenes (Phase 1/Phase 2)
Oropharyngeal Neoplasms (Phase 2/Phase 3)
Osteosarcoma (Phase 2)
Ovarian Diseases (Phase 1)
Ovarian Neoplasms (Phase 2)
Paget Disease, Extramammary (Phase 2)
Pancreatic Neoplasms (Phase 2)
Papilloma (Phase 1)
Papillomaviridae (Phase 2)
Paraganglioma (Phase 2)
Penile Neoplasms (Phase 2)
Peritoneal Cavity (Phase 3)
Peritoneal Neoplasms (Phase 2)
Perivascular Epithelioid Cell Neoplasms (Phase 2)
Pharyngeal Neoplasms (Phase 1/Phase 2)
Pharynx (Phase 2)
Pheochromocytoma (Phase 2)
Pituitary Diseases (Phase 2)
Pituitary Neoplasms (Phase 2)
Plasmablastic Lymphoma (Phase 2)
Plasmacytoma (Phase 2)
Pleural Effusion, Malignant (Phase 2)
Pneumonia, Viral (Phase 2)
Polycythemia Vera (Phase 2)
Polymyalgia Rheumatica (Phase 1)
Primary Myelofibrosis (Phase 2)
Prostatic Diseases (Phase 2)
Prostatic Neoplasms (Phase 3)
Proto-Oncogene Proteins B-raf (Phase 2)
Pseudomyxoma Peritonei (Phase 2)
Psoriasis (Phase 1)
Rectal Neoplasms (Phase 3)
Rhabdoid Tumor (Phase 2)
Rhabdomyosarcoma (Phase 1/Phase 2)
Salivary Gland Neoplasms (Phase 2)
Sarcoma (Phase 3)
Sarcoma, Ewing (Phase 2)
Sarcoma, Kaposi (Phase 2)
Sarcoma, Synovial (Phase 1)
SARS-CoV-2 (Phase 2)
Scleroderma, Systemic (Phase 1)
Sclerosis (Phase 2)
Seminoma (Phase 2)
Sepsis (Phase 1)
Sezary Syndrome (Phase 2)
Sjogren's Syndrome (Phase 1)
Skin Neoplasms (Phase 3)
Small Cell Lung Carcinoma (Phase 3)
Smoldering Multiple Myeloma (Phase 2)
Splenomegaly (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 3)
Stomach Neoplasms (Phase 3)
Survival (Phase 2)
Testicular Neoplasms (Phase 2)
Thymoma (Phase 2)
Thyroid Cancer, Papillary (Phase 1/Phase 2)
Thyroid Neoplasms (Phase 2)
Tobacco Smoking (Phase 2)
Tracheal Neoplasms (Phase 2)
Translocation, Genetic (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Ulcer (Phase 2)
Ureteral Neoplasms (Phase 2)
Urethral Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Urogenital Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 3)
Uterine Diseases (Phase 1/Phase 2)
Uterine Neoplasms (Phase 2)
Uterus (Phase 2)
Vaginal Neoplasms (Phase 2)
Vulvar Neoplasms (Phase 2)
Waldenstrom Macroglobulinemia (Phase 1/Phase 2)
Wilms Tumor (Phase 1)
Xeroderma Pigmentosum (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
